Want to see CNSP full AI Analyst Report?
CNS Pharmaceuticals (CNSP) Income Statement
1,098 Followers
CNS Pharmaceuticals Income Statement
Last quarter (Q2 2026), CNS Pharmaceuticals's total revenue was $0.00. In Q2, CNS Pharmaceuticals's net income was $-2.59M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -3.31K | $ -4.13K | $ -11.76K | $ -13.07K | |
| $ 15.99M | $ 14.90M | $ 18.86M | $ 14.92M | $ 14.47M | |
| Depreciation and Amortization | $ 3.92K | $ 3.31K | $ 4.13K | $ 11.76K | $ 13.07K |
| $ -15.83M | $ -14.84M | $ -18.83M | $ -15.26M | $ -14.47M | |
| $ -15.99M | $ -14.90M | $ -18.87M | $ -14.93M | $ -14.49M | |
| $ 136.00K | $ 44.14K | $ 13.88K | $ -341.17K | $ -9.29K | |
| $ -15.85M | $ -14.86M | $ -18.85M | $ -15.27M | $ -14.50M | |
| $ -15.85M | $ -14.86M | $ -18.85M | $ -15.27M | $ -14.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -35.75 | $ -466.44 | $ -150114.00 | $ -336499.00 | $ -495027.00 |
| Diluted EPS | $ -35.75 | $ -466.44 | $ -150114.00 | $ -336499.00 | $ -495027.00 |
| Weighted Average Shares Outstanding | 443.37K | 31.85K | 126 | 45 | 29 |
| Weighted Average Shares Outstanding (Diluted) | 443.37K | 31.85K | 126 | 45 | 29 |
Currency in USD
